发表B7H3向BiTE的工程瘤病毒增强了抗瘤T细胞免疫反应
Haoran Zhu1, Wanrong Zhang1, Qingguo Guo1
1Department of Biochemistry and Molecular Biology, China Medical University, Shenyang, China.
Journal for immunotherapy of cancer
|November 30, 2024
概括
编码为B7H3双特异性T细胞参与剂 (BiTEs) 的瘤性腺病毒有效向B7H3阳性瘤. 这种方法可以增强T细胞激活和抗瘤免疫力,同时最大限度地减少癌症免疫疗法的全身毒性.
科学领域:
- 瘤治疗性病毒疗法
- 癌症免疫疗法癌症免疫疗法
- 分子工程是分子工程.
背景情况:
- 双特异性T细胞参与剂 (BiTE) 刺激T细胞对抗癌症的免疫力.
- B7H3是有前途的泛癌点,但针对B7H3的BTE面临系统性毒性挑战.
- 瘤病毒 (OVs) 提供了治疗性基因表达的本地区域传递.
研究的目的:
- 设计一种编码针对B7H3的BiTE的瘤性腺病毒 (OAd).
- 评估假设OVs可以持续向瘤输送B7H3BiTE,激活T细胞对抗癌细胞.
主要方法:
- 通过将B7H3特异性和CD3特异性单链变量片段联系起来,构建了一个针对B7H3的BiTE.
- 将B7H3 BiTE插入一个瘤性腺病毒 (OAd-B7H3-BiTE).
- 通过共同培养试验在体外评估BiTE功能,并使用人性化的免疫系统小鼠模型在体内评估治疗效果.
主要成果:
- B7H3在各种人类恶性瘤中高度表达.
- OAd-B7H3-BiTE证明了成功的T细胞结合,激活 (聚类,增殖,细胞因子分泌) 和对B7H3+瘤细胞的细胞毒性.
- 在体内研究证实了B7H3 BiTE的持续瘤表达和增强的抗瘤T细胞免疫反应.
结论:
- 通过OV进行B7H3BiTE的局部表达最大限度地提高治疗度,并最大限度地减少全身暴露.
- OVs为BiTE功能创造了有利的微环境,并将T细胞重定向到瘤.
- B7H3-BiTE武装的OVs代表了对B7H3-阳性恶性瘤的有前途的治疗策略.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.3K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
相关概念视频
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Immune Response Against Viral Pathogens
751
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
751
Cancer Vaccines
340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
